Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Canadian (TSX) Pharma Industry Analysis

UpdatedMay 20, 2026
DataAggregated Company Financials
Companies56
  • 7D-8.3%
  • 3M6.1%
  • 1Y35.2%
  • YTD-9.3%

Over the last 7 days, the Pharma industry has dropped 8.3%, driven by Curaleaf Holdings declining 15%. Meanwhile, Quantum BioPharma actually outperformed within the industry, gaining 43% in the last week. This takes the industry's 12 month performance to a gain of 35%. Looking forward, earnings are forecast to grow by 41% annually.

Industry Valuation and Performance

Has the Canadian Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 21 May 2026CA$15.4bCA$12.1b-CA$1,889,680,009.318.1x-8.2x1.3x
Sat, 18 Apr 2026CA$14.8bCA$11.2b-CA$1,665,105,033.8614.5x-8.9x1.3x
Mon, 16 Mar 2026CA$14.2bCA$11.2b-CA$1,726,830,917.8311.4x-8.2x1.3x
Wed, 11 Feb 2026CA$14.6bCA$11.2b-CA$1,888,156,981.0415.4x-7.7x1.3x
Fri, 09 Jan 2026CA$16.2bCA$11.3b-CA$1,955,404,028.6716.8x-8.3x1.4x
Sun, 07 Dec 2025CA$14.3bCA$11.3b-CA$1,917,133,404.8614.4x-7.5x1.3x
Tue, 04 Nov 2025CA$16.1bCA$11.3b-CA$2,044,635,921.4831x-7.9x1.4x
Thu, 02 Oct 2025CA$17.1bCA$11.3b-CA$2,044,122,507.3434.6x-8.4x1.5x
Sat, 30 Aug 2025CA$18.5bCA$11.8b-CA$2,530,166,398.7940.8x-7.3x1.6x
Mon, 28 Jul 2025CA$11.8bCA$11.7b-CA$2,536,796,300.5917.1x-4.7x1x
Wed, 25 Jun 2025CA$9.5bCA$11.7b-CA$2,523,261,791.7716.5x-3.8x0.8x
Fri, 23 May 2025CA$24.1bCA$11.9b-CA$2,410,554,493.4717.6x-10x2x
Sun, 20 Apr 2025CA$9.7bCA$12.0b-CA$2,565,281,498.6519.1x-3.8x0.8x
Tue, 18 Mar 2025CA$10.6bCA$12.2b-CA$2,636,450,409.7919.3x-4x0.9x
Thu, 13 Feb 2025CA$12.4bCA$12.1b-CA$2,222,308,068.2023.8x-5.6x1x
Sat, 11 Jan 2025CA$12.7bCA$12.2b-CA$2,417,169,184.2728.7x-5.2x1x
Mon, 09 Dec 2024CA$13.6bCA$12.0b-CA$2,579,625,132.8521.9x-5.3x1.1x
Wed, 06 Nov 2024CA$19.5bCA$11.8b-CA$2,759,274,704.7518.3x-7.1x1.6x
Fri, 04 Oct 2024CA$18.2bCA$11.6b-CA$2,678,284,898.6127.4x-6.8x1.6x
Sun, 01 Sep 2024CA$17.1bCA$11.6b-CA$2,690,218,404.9420.2x-6.4x1.5x
Tue, 30 Jul 2024CA$20.1bCA$11.7b-CA$3,219,584,437.5222.6x-6.2x1.7x
Thu, 27 Jun 2024CA$19.9bCA$11.8b-CA$3,240,059,966.8618.7x-6.1x1.7x
Sat, 25 May 2024CA$21.9bCA$11.9b-CA$3,490,510,696.0612.8x-6.3x1.8x
Mon, 22 Apr 2024CA$23.2bCA$12.0b-CA$3,476,028,729.958.2x-6.7x1.9x
Wed, 20 Mar 2024CA$22.7bCA$11.9b-CA$3,488,802,775.759.5x-6.5x1.9x
Fri, 16 Feb 2024CA$21.4bCA$12.0b-CA$4,645,073,912.3410.7x-4.6x1.8x
Sun, 14 Jan 2024CA$20.3bCA$12.3b-CA$6,744,251,485.009.3x-3x1.6x
Tue, 12 Dec 2023CA$18.9bCA$12.4b-CA$6,778,155,055.008.5x-2.8x1.5x
Thu, 09 Nov 2023CA$16.5bCA$12.5b-CA$7,345,316,347.0011.1x-2.2x1.3x
Sat, 07 Oct 2023CA$18.6bCA$12.4b-CA$7,334,645,428.0015x-2.5x1.5x
Mon, 04 Sep 2023CA$17.9bCA$13.0b-CA$7,881,604,052.0013.3x-2.3x1.4x
Wed, 02 Aug 2023CA$15.3bCA$13.2b-CA$9,722,211,074.0011.9x-1.6x1.2x
Fri, 30 Jun 2023CA$14.8bCA$13.2b-CA$9,522,549,372.0012x-1.6x1.1x
Sun, 28 May 2023CA$14.9bCA$13.4b-CA$10,471,665,836.0010.2x-1.4x1.1x
Price to Earnings Ratio

-1.4x


Total Market Cap: CA$14.9bTotal Earnings: -CA$10,471,665,836.00Total Revenue: CA$13.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Pharma Industry Price to Earnings3Y Average -5.5x202420252026
Current Industry PE
  • Investors are relatively neutral on the Canadian Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 1.4x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 3.3% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Trends

Which industries have driven the changes within the Canadian Healthcare industry?

CA Market-1.95%
Healthcare-4.92%
Pharma-8.32%
Pharma-8.32%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
QNTM Quantum BioPharmaCA$10.9643.3%
+CA$19.3m		-35.9%PB78.1x
NVRS Noveris Health SciencesCA$1.9713.2%
+CA$13.5m		688.0%PE39.5x
GRIN Grown Rogue InternationalCA$0.5410.2%
+CA$12.5m		1.9%PS2.9x
ACB Aurora CannabisCA$4.773.7%
+CA$10.1m		-33.8%PS0.8x
EPIC 1CMCA$0.2039.3%
+CA$6.5m		n/aPE5.3x

Latest News

QNTM
CA$10.96
Quantum BioPharma
7D
43.3%
1Y
-35.9%
CRON
CA$3.69
Cronos Group
7D
-1.3%
1Y
28.6%
GUD
CA$8.18
Knight Therapeutics
7D
-3.7%
1Y
42.0%
WEED
CA$1.43
Canopy Growth
7D
-4.7%
1Y
-42.3%
VRNO
CA$1.42
Verano Holdings
7D
-11.3%
1Y
49.5%
GRIN
CA$0.54
Grown Rogue International
7D
10.2%
1Y
1.9%
CPH
CA$16.92
Cipher Pharmaceuticals
7D
-5.8%
1Y
39.8%
Analysis Article • May 14

Investors Shouldn't Be Too Comfortable With Cipher Pharmaceuticals' (TSE:CPH) Earnings

Cipher Pharmaceuticals Inc. ( TSE:CPH ) announced strong profits, but the stock was stagnant. Our analysis suggests...
DB
CA$0.13
Decibel Cannabis
7D
8.3%
1Y
100.0%
GTII
CA$9.93
Green Thumb Industries
7D
-3.9%
1Y
30.0%
ACB
CA$4.77
Aurora Cannabis
7D
3.7%
1Y
-33.8%
TRUL
CA$10.98
Trulieve Cannabis
7D
-3.6%
1Y
84.5%
EPIC
CA$0.20
1CM
7D
39.3%
1Y
n/a
Analysis Article • May 07

1CM's (CSE:EPIC) Earnings Are Of Questionable Quality

Despite posting some strong earnings, the market for 1CM Inc.'s ( CSE:EPIC ) stock hasn't moved much. Our analysis...
CURA
CA$4.56
Curaleaf Holdings
7D
-15.4%
1Y
289.7%
RVV
CA$0.04
Revive Therapeutics
7D
33.3%
1Y
60.0%
NVRS
CA$1.97
Noveris Health Sciences
7D
13.2%
1Y
688.0%
PCLO
CA$0.10
PharmaCielo
7D
42.9%
1Y
100.0%